Anavex Life Sciences Corp (AVXL)

[XenaLives]

Bingo!

The disparity of Market Caps between ACAD ($2.8 Bil. and as high as $5 Bil.) and AVXL ($122 Mil) is staggering, 23X. What would a similar valuation of Anaxex do to the price of AVXL stock? One does not have to have a great imagination to see what Anavex should be valued at today. Just examine the market caps of other CNS clinical stage companies like ACAD and Sage ($7 Bil with NO APPROVALS) or like AXON ($2.4 Bil, before) in its, Wall Street sponsored pre-clinical pump stage. Why is AVXL stock priced so low? That is the $63(thousand) question and may be partly due to Anavex not being a Wall Street Sponsored/Controlled company having not IPO'd with the controlling stock interests in the hands of Wall Street. Is Wall Street getting their shares by running over and running out retail holders as best they can with manipulation?